Equine Healthcare Market Analysis

Equine Healthcare Market Analysis

Based on product, the market is segmented into vaccines, pharmaceuticals, medicinal feed additives, diagnostics, and other products. A range of equine pharmaceuticals, including analgesics, anti-infectives, anti-inflammatories, and parasiticides, is utilized in the treatment of various conditions like reproductive, metabolic, infectious, and dermatological disorders in horses. In the year 2022, pharmaceuticals dominated the market with a substantial share of 32.8%.
 

• The market for both prescription and non-prescription medications has expanded due to increased spending on equestrian and equine health, driven by the efforts of industry participants. For example, Zoetis offers a wide array of medications, including equine parasiticides like the QUEST gel, Equest Pramox, Deosect 5% Spray Solution, among others.
   
• Similarly, in December 2022, the U.S. Food and Drug Administration (FDA) granted approval for Zycosan, a Anzac Animal Health LLC product, to manage clinical symptoms linked to osteoarthritis in horses.
   

Based on indication, the equine healthcare market is classified into musculoskeletal disorders, parasite control, equine herpes, equine encephalomyelitis, equine influenza, tetanus, West Nile Virus, and other indications. The parasite control segment is expected to reach USD 853.5 million by 2032.
 

• Parasites, such as internal worms as well as external nuisances such as ticks and flies, can significantly impair equine health, resulting in a range of problems, including weight loss, colic, and skin irritations.
   
• Progress in parasite control products and techniques has also propelled the expansion of this sector. Pharmaceutical companies have devised anthelmintic drugs that are both more efficient and safer, enabling more precise and strategic deworming practices.
   

Based on distribution channel, the equine healthcare market is classified into veterinary hospital pharmacies, e-commerce, and other distribution channel. The veterinary hospital pharmacies segment accounted for USD 798.3 million in 2022.
 

• Veterinary hospital pharmacies and clinics have asserted dominance in the equine healthcare industry due to their central role in providing essential healthcare services and products.
   
• These hubs provide an extensive spectrum of medications, therapies, and expert advice for equine health conditions, establishing themselves as the primary choice for horse owners in search of professional healthcare and pharmaceutical remedies.
  
   

The North America equine healthcare market is expected to grow at 6.2% by 2032.
 

• The presence of horse farms and the annual horse racing events significantly contribute to the overall equine population in the region. Rising cases of equine disease has propelled the industry. For instance, according to a study published in National Center for Biotechnology Information (NCBI), eastern equine encephalitis (EEE) is among the most severe arboviral encephalitis diseases found in the U.S. It is currently categorized as an emerging disease, with a consistent rise in the number of reported cases across a broader population. It is noted that annually, the U.S. reports between six to eight cases, primarily occurring from May to October, and most frequently observed in states such as Florida, Georgia, Maryland, Wisconsin, and New Jersey.